Towards Healthcare Research & Consulting
Insulin Pump Market
Updated Date: 29 July 2026   |   Report Code: 5025
[email protected] +1 804-441-9344
Download Sample Order Now

Insulin Pump Market Trends, Growth and Market Size Analysis 2035

Projections indicate the global insulin pump market will increase from USD 7.53 billion in 2025 to USD 18.93 billion by 2035, experiencing a growth over the next 10 years. The insulin pump market is growing rapidly, driven by rising diabetes cases, technological advances like smartphone integration, and demand for user-friendly, minimally invasive devices. Emerging trends include artificial intelligence, closed-loop systems, and expanding adoption in developing regions.

Last Updated : 29 July 2026 Category: Medical Devices Insight Code: 5025 Format: PDF / PPT / Excel

Content

Executive Summary

  • Market Snapshot
  • Key Trends
  • Market Dynamics
  • Summary of Key Findings

Introduction

  • Definition and Scope
  • Research Methodology
  • Assumptions and Limitations

Market Dynamics

  • Drivers
    • Increasing Prevalence of Diabetes
    • Technological Advancements
    • Growing Awareness and Adoption
  • Restraints
    • High Cost of Insulin Pumps
    • Reimbursement Issues
  • Opportunities
    • Emerging Markets
    • Innovations in Insulin Delivery Systems
  • Challenges
    • Regulatory Hurdles
    • Market Competition

Market Segmentation

  • By Pump Type (Value and Volume)
    • Tethered Pump
    • Patch Pump
    • Implanted Insulin Pump
    • Closed Loop Insulin Pump
  • By Product (Value and Volume)
    • MiniMed (630G, 670G, and VEO)
    • Accu-Chek (Combo, Insight, and Solo)
    • Tandem (T: slim X2, G4, T: flex Delivery System)
    • Omnipod
    • My life omnipod
    • Others
  • By Application (Value and Volume)
    • Battery
    • Insulin Set Insertion Devices
    • Insulin Reservoir
  • By Disease Indication (Value and Volume)
    • Type 1 Diabetes
    • Type 2 Diabetes
  • By End User (Value and Volume)
    • Hospitals
    • Clinics
    • Homecare
    • Laboratories
  • By Geography (Value and Volume)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
    • Rest of the World

Detailed Cross-Segment Analysis

Pump Type vs. Product

  • Tethered Pump
    • MiniMed (630G, 670G, and VEO)
      • Value: $X billion
      • Volume: X units
    • Accu-Chek (Combo, Insight, and Solo)
      • Value: $X billion
      • Volume: X units
    • Tandem (T: slim X2, G4, T: flex Delivery System)
      • Value: $X billion
      • Volume: X units
    • Omnipod
      • Value: $X billion
      • Volume: X units
    • My life omnipod
      • Value: $X billion
      • Volume: X units
    • Others
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • MiniMed (630G, 670G, and VEO)
      • Value: $X billion
      • Volume: X units
    • Accu-Chek (Combo, Insight, and Solo)
      • Value: $X billion
      • Volume: X units
    • Tandem (T: slim X2, G4, T: flex Delivery System)
      • Value: $X billion
      • Volume: X units
    • Omnipod
      • Value: $X billion
      • Volume: X units
    • My life omnipod
      • Value: $X billion
      • Volume: X units
    • Others
      • Value: $X billion
      • Volume: X units

Pump Type vs. Application

  • Tethered Pump
    • Battery
      • Value: $X billion
      • Volume: X units
    • Insulin Set Insertion Devices
      • Value: $X billion
      • Volume: X units
    • Insulin Reservoir
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Battery
      • Value: $X billion
      • Volume: X units
    • Insulin Set Insertion Devices
      • Value: $X billion
      • Volume: X units
    • Insulin Reservoir
      • Value: $X billion
      • Volume: X units

Pump Type vs. Disease Indication

  • Tethered Pump
    • Type 1 Diabetes
      • Value: $X billion
      • Volume: X units
    • Type 2 Diabetes
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Type 1 Diabetes
      • Value: $X billion
      • Volume: X units
    • Type 2 Diabetes
      • Value: $X billion
      • Volume: X units

Pump Type vs. End User

  • Tethered Pump
    • Hospitals
      • Value: $X billion
      • Volume: X units
    • Clinics
      • Value: $X billion
      • Volume: X units
    • Homecare
      • Value: $X billion
      • Volume: X units
    • Laboratories
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Hospitals
      • Value: $X billion
      • Volume: X units
    • Clinics
      • Value: $X billion
      • Volume: X units
    • Homecare
      • Value: $X billion
      • Volume: X units
    • Laboratories
      • Value: $X billion
      • Volume: X units

Pump Type vs. Geography

  • Tethered Pump
    • North America
      • U.S.
        • Value: $X billion
        • Volume: X units
      • Canada
        • Value: $X billion
        • Volume: X units
    • Europe
      • U.K.
        • Value: $X billion
        • Volume: X units
      • Germany
        • Value: $X billion
        • Volume: X units
      • France
        • Value: $X billion
        • Volume: X units
      • Rest of Europe
        • Value: $X billion
        • Volume: X units
    • Asia Pacific
      • China
        • Value: $X billion
        • Volume: X units
      • India
        • Value: $X billion
        • Volume: X units
      • Japan
        • Value: $X billion
        • Volume: X units
      • South Korea
        • Value: $X billion
        • Volume: X units
      • Rest of Asia Pacific
        • Value: $X billion
        • Volume: X units
    • Rest of the World
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • North America
      • U.S.
        • Value: $X billion
        • Volume: X units
      • Canada
        • Value: $X billion
        • Volume: X units
    • Europe
      • U.K.
        • Value: $X billion
        • Volume: X units
      • Germany
        • Value: $X billion
        • Volume: X units
      • France
        • Value: $X billion
        • Volume: X units
      • Rest of Europe
        • Value: $X billion
        • Volume: X units
    • Asia Pacific
      • China
        • Value: $X billion
        • Volume: X units
      • India
        • Value: $X billion
        • Volume: X units
      • Japan
        • Value: $X billion
        • Volume: X units
      • South Korea
        • Value: $X billion
        • Volume: X units
      • Rest of Asia Pacific
        • Value: $X billion
        • Volume: X units
    • Rest of the World
      • Value: $X billion
      • Volume: X units

Competitive Landscape

  • Market Share Analysis
  • Key Developments
  • Company Profiles
    • Medtronic Plc
    • Insulet Corporation
    • Medzer
    • Microport Scientific
    • Eoflow
    • Debiotech S.A.
    • Lenomed Medical
    • Microtech Medical
    • Cequr SA
    • F. Hoffmann La Roche AG
    • Ypsomed AG
    • Zealand Pharma
    • Terumo Corporation
    • Vicentra B.V.

Technological Analysis

  • Innovations in Insulin Pump Technology
  • Integration with Continuous Glucose Monitoring (CGM)
  • Development of Artificial Pancreas Systems

Regulatory Framework

  • Overview of Regulatory Bodies
  • Key Regulations and Guidelines
  • Impact of Regulatory Changes on the Market

Investment Analysis

  • Recent Investments
  • Mergers & Acquisitions
  • Partnership & Collaborations

Appendix

  • List of Abbreviations
  • Methodology
  • Primary Research Insights
  • Secondary Research Sources
  • Disclaimer

FAQ's

Answer : The insulin pump market is set for strong, steady growth, expanding at a CAGR of 9.65% from 2026 to 2035. Valued at USD 8.26 billion in 2026, it is projected to reach USD 18.93 billion by 2035.

Answer : Major trends include the rise of AI-powered closed-loop insulin systems, tighter integration with continuous glucose monitoring (CGM), and growing demand for patch pumps

Answer : Market leaders like Medtronic, Tandem Diabetes Care, and Insulet are driving innovation through AI-enabled pumps, CGM integration, and miniaturized designs.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar